Nova Digm Therapeutics Inc
Advertisement
NovaDigm Therapeutics Inc is a biotechnology company based in Grand Forks, ND, dedicated to developing innovative immunotherapeutics and preventative vaccines for fungal and bacterial diseases. Their lead development candidate, NDV-3A, has shown promising preclinical efficacy in reducing the severity of diseases caused by both fungal and bacterial pathogens, making it a potential breakthrough in the field.
Currently in Phase 2 clinical development for recurrent vulvovaginal candidiasis (RVVC), NDV-3A is also being explored for future indications in Candida, including nosocomial candidiasis, a severe and life-threatening infection, as well as Staphylococcus aureus, including MRSA. NovaDigm Therapeutics aims to address the challenges of recurrent, drug-resistant, and potentially life-threatening fungal and bacterial diseases through their innovative approach.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.
Advertisement